Record check
Did the record support “FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome”?
Evidence state
developing
A dated primary-source record, attributable response, or correction that confirms, narrows, or resolves: FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome.
Receipts
- captured headline
FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome
This page is a source-linked record. It does not score a person, infer motive, or replace the preserved source material.